First RI Symposium: Policy, Economics & Science: Implications for the Future of Nephrology

Summary and Panel Discussion. The Affordable Care Act, Influencing Public Policy to Create Better Health For Those With Kidney Disease, Rogosin's Unique Advantage and Model. Key Provisions of the Patient Protection and Affordable Care Act and the Opportunities for Nephrology Given the New Legislation, Patient Centered Medicine. The European Perspective: Introducing eGFR to Patients in Sweden. Question and Answer Panel Discussion.

Center for Medicare and Medicaid Services Overview, CMS Core Work and Strategies to Ensure Quality and Value, ESRD Quality Incentive Program, Improving Medicare, Access to Services, The Affordable Care Act and Chronic Kidney Disease and End Stage Renal Disease, The Future of Kidney Care and a Collaborative Proposal for the Future of Chronic Kidney Disease Treatment

Implications for the Future of Nephrology

Risk Management: The Core of Risk Management, Clinical and Financial Risk, the Clinician as the Business Risk Manager, Care as an Experimental Process, Re-Thinking the Medical Record, Unified Risk Management: Lifestyle Risk, Financial Risk, and Clinical Risk. The Rogosin Institutes Unified Patient Centric Approach as an Example.

The History and Future of Transplants. The First Successful Organ Transplantation and a History of Kidney Transplants, Current Organ Specific Transplant Success Rates, Drugs That Have Transformed Transplantation, Clinical Management of the Transplant Recipient, New York Presbyterian Hospitals/Weil Cornell/Rogosin Institute Transplantation Program, and Renal Transplant Rejection and Tolerance.

Future of Dialysis: Science, Technology, and Quality of Life: Unmet Medical Needs and Mortality Rates and Mortality in Renal Failure

The Rogosin Experience: Why its different and an example of how Rogosin utilizes a medical information system.